Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Saved in:
| Title: | Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study. |
|---|---|
| Authors: | Beldi-Ferchiou A; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., Jais JP; Biostatistics Unit, APHP, Univ Paris Descartes, Paris, France., Ghesquieres H; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France., Casasnovas RO; Hematology, CHU Dijon Bourgogne and INSERM U 1231, Dijon, France., Tilly H; INSERM U918, Centre Henri Becquerel, Rouen, France., Fruchart C; Institut d'Hématologie de Basse Normandie, CHU Caen, Caen, France., Morschhauser F; Clinical Hematology, Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Haioun C; Lymphoid Malignancies Unit, APHP, Hopital Henri Mondor, Creteil, France., Lazarovici J; Clinical Hematology, Gustave Roussy Cancer Center, Villejuif, France., Perrot A; Hematology department, CHU Brabois, Vandoeuvre les Nancy, France., Nicolas-Virelizier E; Onco Hematology, Centre Leon Berard, Lyon, France., Salles G; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France., Godard N; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., Zamali I; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., De Colella JS; Onco Hematology, Institut Paoli Calmettes, Marseille, France., Claudel A; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France., Corront B; Hematology, CH Annecy Genevois, Epagny Metz-Tessy, France., Oberic L; Hematology, IUC - Oncopole CHU Toulouse, Toulouse, France., Briere J; Pathology, APHP, Hopital Saint-Louis, Paris, France., Gaulard P; AP-HP, Henri Mondor Hospital, Pathology Department, Créteil, France.; Univ Paris Est Créteil, INSERM, IMRB, Créteil, France., Thieblemont C; Assistante publique - Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI, Université de Paris, Paris, France., Delfau-Larue MH; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France. |
| Source: | British journal of haematology [Br J Haematol] 2023 Apr; Vol. 201 (2), pp. 256-266. Date of Electronic Publication: 2023 Feb 06. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36740991 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Beldi-Ferchiou+A%22">Beldi-Ferchiou A</searchLink>; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22Jais+JP%22">Jais JP</searchLink>; Biostatistics Unit, APHP, Univ Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ghesquieres+H%22">Ghesquieres H</searchLink>; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Casasnovas+RO%22">Casasnovas RO</searchLink>; Hematology, CHU Dijon Bourgogne and INSERM U 1231, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Tilly+H%22">Tilly H</searchLink>; INSERM U918, Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Fruchart+C%22">Fruchart C</searchLink>; Institut d'Hématologie de Basse Normandie, CHU Caen, Caen, France.<br /><searchLink fieldCode="AU" term="%22Morschhauser+F%22">Morschhauser F</searchLink>; Clinical Hematology, Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.<br /><searchLink fieldCode="AU" term="%22Haioun+C%22">Haioun C</searchLink>; Lymphoid Malignancies Unit, APHP, Hopital Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22Lazarovici+J%22">Lazarovici J</searchLink>; Clinical Hematology, Gustave Roussy Cancer Center, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; Hematology department, CHU Brabois, Vandoeuvre les Nancy, France.<br /><searchLink fieldCode="AU" term="%22Nicolas-Virelizier+E%22">Nicolas-Virelizier E</searchLink>; Onco Hematology, Centre Leon Berard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Salles+G%22">Salles G</searchLink>; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Godard+N%22">Godard N</searchLink>; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22Zamali+I%22">Zamali I</searchLink>; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22De+Colella+JS%22">De Colella JS</searchLink>; Onco Hematology, Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Claudel+A%22">Claudel A</searchLink>; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22Corront+B%22">Corront B</searchLink>; Hematology, CH Annecy Genevois, Epagny Metz-Tessy, France.<br /><searchLink fieldCode="AU" term="%22Oberic+L%22">Oberic L</searchLink>; Hematology, IUC - Oncopole CHU Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Briere+J%22">Briere J</searchLink>; Pathology, APHP, Hopital Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gaulard+P%22">Gaulard P</searchLink>; AP-HP, Henri Mondor Hospital, Pathology Department, Créteil, France.; Univ Paris Est Créteil, INSERM, IMRB, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Thieblemont+C%22">Thieblemont C</searchLink>; Assistante publique - Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Delfau-Larue+MH%22">Delfau-Larue MH</searchLink>; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2023 Apr; Vol. 201 (2), pp. 256-266. <i>Date of Electronic Publication: </i>2023 Feb 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36740991 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.18642 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 256 Titles: – TitleFull: Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Beldi-Ferchiou A – PersonEntity: Name: NameFull: Jais JP – PersonEntity: Name: NameFull: Ghesquieres H – PersonEntity: Name: NameFull: Casasnovas RO – PersonEntity: Name: NameFull: Tilly H – PersonEntity: Name: NameFull: Fruchart C – PersonEntity: Name: NameFull: Morschhauser F – PersonEntity: Name: NameFull: Haioun C – PersonEntity: Name: NameFull: Lazarovici J – PersonEntity: Name: NameFull: Perrot A – PersonEntity: Name: NameFull: Nicolas-Virelizier E – PersonEntity: Name: NameFull: Salles G – PersonEntity: Name: NameFull: Godard N – PersonEntity: Name: NameFull: Zamali I – PersonEntity: Name: NameFull: De Colella JS – PersonEntity: Name: NameFull: Claudel A – PersonEntity: Name: NameFull: Corront B – PersonEntity: Name: NameFull: Oberic L – PersonEntity: Name: NameFull: Briere J – PersonEntity: Name: NameFull: Gaulard P – PersonEntity: Name: NameFull: Thieblemont C – PersonEntity: Name: NameFull: Delfau-Larue MH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2023 Apr Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 201 – Type: issue Value: 2 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |